Rucaparib Completed Phase 2 Trials for brca2 Mutation Carrier / Cancer, Breast / Cancer of the Ovary / brca1 Mutation Carrier Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00664781Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer